This paper investigated the immunoreactivity and thioflavine S staining of Alzheimer’s and non-Alzheimer’s disease brain specimens stored as formalin-fixed, paraffin-embedded (FFPE) blocks for up to 31 years or stored in formalin for up to 51 years.
Archival, formalin-fixed tissue: its use in the study of Alzheimer's type changes.
Dwork AJ, Prohovnik I, Kaufman MA, Liu D
Purpose
Conclusion
Senile plaques, neurofibrillary tangles, and Alzheimer’s disease markers were absent in non-Alzheimer’s cases and were detected in all Alzheimer’s cases. Counts of senile plaques and neurofibrillary tangles obtained after storage were consistent with original counts determined by Von Braunmuhl silver staining for the 6 Alzheimer’s disease cases. Expected patterns of immunohistochemical staining were observed in Alzheimer’s diseases specimens stored as FFPE blocks for 26-31 years for each of the antibodies evaluated. Conversely, Alzheimer’s disease specimens stored in formalin for 49-51 years displayed no Alz 50 (tau) immunoreactivity regardless of formic acid pretreatment; interestingly, the immunoreactivity of the other antibodies evaluated remained detectable in specimens stored for up to 51 years in formalin as long as a formic acid pretreatment step was performed. In the follow-up study, senile plaques and neurofibrillary tangles were observed in all Alzheimer’s cases, although some cases did not meet the current threshold for an Alzheimer’s disease diagnosis. Alz 50 immunoreactivity was observed in all specimens, representing 3 cases, stored in formalin for 9 years. The three cases stored in formalin for 19-20 years displayed some Alz 50 immunoreactivity, but the authors reported that there was appreciable loss; Alz 50 immunoreactivity was absent from all specimens stored in formalin for 29-30 or 36-39 years. The authors concluded that specimens stored at FFPE blocks for up to 31 years and in formalin for up to 51 years can be used for the immunohistochemical identification of senile plaques and neurofibrillary tangles but that immunoreactivity of Alz 50 is lost when stored in formalin for >10 years.
Studies (1)
Purpose
This study investigated the immunoreactivity and thioflavine S staining of Alzheimer’s and non-Alzheimer’s disease brain specimens stored as formalin-fixed, paraffin-embedded (FFPE) blocks for up to 31 years or stored in formalin for up to 51 years. The study included FFPE brain tissue from 7 patients with Alzheimer’s disease and 4 patients without that had been stored 26-31 years and brain tissue from 4 patients with Alzheimer’s disease and 4 without that were stored in formalin (unknown formulation and if replenished) for 49-51 years. In addition, 12 Alzheimer’s disease brains stored in formalin for 9-39 years (3 each for 9 years, 19-20 years, 29-30 years and 36-39 years) were used to further explore the timing of immunoreactivity loss. Formalin-fixed specimens were embedded in paraffin, and sections were stained with thioflavine S. Additional sections were immunohistochemically stained after formic acid pretreatment using antibodies against β-Amyloid (4G8), neurofibrillary tangles (Ab 39), tau (Alz 50), and ubiquitin using a polyclonal (Ubi) antibody. Plaques and tangles were counted by two blinded observers. Immunohistochemical and Thioflavin S staining results were evaluated independently. Results were compared with original Von Braunmuhl silver stains for 6 Alzheimer’s cases and 1 control.
Summary of Findings
Senile plaques, neurofibrillary tangles, and Alzheimer’s disease markers were absent in non-Alzheimer’s cases and were detected in all Alzheimer’s cases. Counts of senile plaques and neurofibrillary tangles obtained after storage were consistent with original counts determined by Von Braunmuhl silver staining for the 6 Alzheimer’s disease cases. Expected patterns of immunohistochemical staining were observed in Alzheimer’s diseases specimens stored as FFPE blocks for 26-31 years for each of the antibodies evaluated. Conversely, Alzheimer’s disease specimens stored in formalin for 49-51 years displayed no Alz 50 (tau) immunoreactivity regardless of formic acid pretreatment; interestingly, the immunoreactivity of the other antibodies evaluated remained detectable in specimens stored for up to 51 years in formalin as long as a formic acid pretreatment step was performed. In the follow-up study, senile plaques and neurofibrillary tangles were observed in all Alzheimer’s cases, although some cases did not meet the current threshold for an Alzheimer’s disease diagnosis. Alz 50 immunoreactivity was observed in all specimens, representing 3 cases, stored in formalin for 9 years. The three cases stored in formalin for 19-20 years displayed some Alz 50 immunoreactivity, but the authors reported that there was appreciable loss; Alz 50 immunoreactivity was absent from all specimens stored in formalin for 29-30 or 36-39 years. The authors concluded that specimens stored at FFPE blocks for up to 31 years and in formalin for up to 51 years can be used for the immunohistochemical identification of senile plaques and neurofibrillary tangles but that immunoreactivity of Alz 50 is lost when stored in formalin for >10 years.
Biospecimens
TissueBrainPreservation Types
FormalinDiagnoses
Alzheimer's DiseaseNot specifiedPlatforms
ProteinImmunohistochemistryMorphologyLight microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Alzheimer’s diseaseNot Alzheimer’s diseaseStorage Storage conditions FFPE blockIn formalinStorage Storage duration As FFPE block for 26-31 yearsIn formalin for 19-20 yearsIn formalin for 29-30 yearsIn formalin for 36-39 yearsIn formalin for 49-51 yearsIn formalin for 9 yearsImmunohistochemistry Specific Targeted peptide/protein Neurofibrillary tangles (Ab 39)Tau (Alz 50)Ubiquitin polyclonal (Ubi)β-Amyloid (4G8)